APA (7th ed.) Citation

C, F., C, B., R, C., M, M., F, C., A, P., . . . A, D. (1986). Long-lasting prolactin-lowering effect of cabergoline, a new dopamine agonist, in hyperprolactinemic patients. The Journal of clinical endocrinology and metabolism, 63(4), 941. https://doi.org/10.1210/jcem-63-4-941

Chicago Style (17th ed.) Citation

C, Ferrari, Barbieri C, Caldara R, Mucci M, Codecasa F, Paracchi A, Romano C, Boghen M, and Dubini A. "Long-lasting Prolactin-lowering Effect of Cabergoline, a New Dopamine Agonist, in Hyperprolactinemic Patients." The Journal of Clinical Endocrinology and Metabolism 63, no. 4 (1986): 941. https://doi.org/10.1210/jcem-63-4-941.

MLA (9th ed.) Citation

C, Ferrari, et al. "Long-lasting Prolactin-lowering Effect of Cabergoline, a New Dopamine Agonist, in Hyperprolactinemic Patients." The Journal of Clinical Endocrinology and Metabolism, vol. 63, no. 4, 1986, p. 941, https://doi.org/10.1210/jcem-63-4-941.